Register Login
Register to leave comments
  • News bot April 16, 2026, 8:49 p.m.

    📋 ACHIEVE LIFE SCIENCES, INC. (ACHV) - Clinical Trial Update

    Filing Date: 2026-04-16

    Accepted: 2026-04-16 16:47:39

    Event Type: Clinical Trial Update

    Event Details:

    ACHIEVE LIFE SCIENCES, INC. (ACHV) Announces Clinical Trial Update ACHIEVE LIFE SCIENCES, INC. (ACHV) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: treatment
    • Diseases/Conditions: nicotine dependence, gross proceeds up to approximately $354 million
    • Collaboration: LifeSci Venture Partners

    🔬 Clinical Development Pipeline (ACHIEVE LIFE SCIENCES, INC.):

    Product Type Development Stage Therapeutic Area Source
    Behavioral Support BEHAVIORAL Phase PHASE3 Vaping Cessation ClinicalTrials.gov
    Placebo DRUG Phase PHASE3 Vaping Cessation ClinicalTrials.gov
    Cytisinicline DRUG Phase PHASE3 Vaping Cessation ClinicalTrials.gov
    Moxifloxacin DRUG Phase PHASE1 Smoking Cessation ClinicalTrials.gov
    cytisine DRUG Phase PHASE1 Smoking Cessation ClinicalTrials.gov
    Placebo Comparator DRUG Phase PHASE2 Smoking Cessation ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE2 Squamous Cell Lung Cancer ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE2 Squamous Cell Lung Cancer ClinicalTrials.gov
    Apatorsen (OGX-427) DRUG Phase PHASE2 Squamous Cell Lung Cancer ClinicalTrials.gov
    Custirsen DRUG Phase PHASE1 Cardiac Conduction and Repolarization ClinicalTrials.gov
    OGX-427 DRUG Phase PHASE2 Pancreatic Cancer ClinicalTrials.gov
    Docetaxel DRUG Phase PHASE2 Bladder Cancer ClinicalTrials.gov
    Prednisone DRUG Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    Abiraterone Acetate DRUG Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    custirsen sodium DRUG Phase PHASE3 Prostate Cancer ClinicalTrials.gov
    cabazitaxel DRUG Phase PHASE3 Prostate Cancer ClinicalTrials.gov
    Custirsen, paclitaxel and carboplatin DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    Cisplatin DRUG Phase PHASE2 Urologic Neoplasms ClinicalTrials.gov
    OGX-427 1000 mg DRUG Phase PHASE2 Urologic Neoplasms ClinicalTrials.gov
    OGX-427 600 mg DRUG Phase PHASE2 Urologic Neoplasms ClinicalTrials.gov
    Dexamethasone DRUG Phase PHASE3 Prostate Cancer ClinicalTrials.gov
    isotonic, 0.9% sodium chloride DRUG Phase PHASE3 Castrate-Resistant Prostate Cancer ClinicalTrials.gov
    SN2310 Injectable Emulsion DRUG Phase PHASE1 Breast Neoplasms ClinicalTrials.gov
    custirsen (OGX-011)/docetaxel DRUG Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    custirsen (OGX-011)/mitoxantrone DRUG Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    TOCOSOL Paclitaxel DRUG Phase PHASE3 Breast Neoplasm ClinicalTrials.gov
    Taxol DRUG Phase PHASE3 Breast Neoplasm ClinicalTrials.gov
    TOCOSOL(R) Paclitaxel DRUG Phase PHASE2 Breast Cancer ClinicalTrials.gov
    S-8184 Paclitaxel Injectable Emulsion DRUG Phase PHASE2 Colorectal Adenocarcinoma ClinicalTrials.gov
    Experimental Arm: TOCOSOL Paclitaxel DRUG Phase PHASE2 Urologic Neoplasms ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ACHIEVE LIFE SCIENCES, INC.
    • Ticker Symbol: ACHV

Search

News categories